-
Putting Mammalian Embryonic Cells into Dormancy
2026-08-26
This Nature Protocols study translates pharmacological mTOR inhibition into reproducible in vitro workflows for inducing a reversible, diapause-like state in mouse blastocysts, human blastoids, and pluripotent stem cells. Its main contribution is a scalable alternative to invasive in vivo procedures, enabling mechanistic studies of developmental pausing while clearly defining the controls and readouts needed to distinguish dormancy from irreversible damage.
-
VX-765 for Caspase-1 and Pyroptosis
2026-08-25
VX-765 enables targeted investigation of caspase-1 signaling, cytokine maturation, and pyroptotic cell death across biochemical, macrophage, and disease-model workflows. Its active metabolite VRT-043198 supports potent pathway suppression, while recent evidence makes caspase-8 counter-screening essential for rigorous interpretation.
-
Pregnenolone Carbonitrile: PXR Assay Workflows
2026-08-25
Pregnenolone Carbonitrile connects rodent PXR activation with cytochrome P450 CYP3A induction, hepatic detoxification studies, and liver fibrosis research. Its emerging hypothalamic role also supports carefully controlled assays of AVP-linked water homeostasis, provided tissue, species, and genotype limitations are addressed.
-
Sulfaphenazole Derivatives Against TB with Lower CYP2C9
2026-08-24
The reference study optimized sulfaphenazole-derived sulfonamides to preserve antimycobacterial activity while reducing CYP2C9 inhibition, a potential source of drug–drug interactions. Compound 10d emerged as the leading example, combining a Mycobacterium tuberculosis MIC of 5.69 μg/mL with CYP2C9 inhibition weaker than 10 μM, providing a useful medicinal-chemistry framework for safer sulfonamide-based anti-TB discovery.
-
2,7-Dichlorodihydrofluorescein diacetate in PCOS
2026-08-24
A translational guide to using DCFH-DA as a context-aware intracellular ROS readout in granulosa-cell and PCOS research, connecting probe chemistry with THBS1/PI3K/AKT biology, assay controls, and the limits of mechanistic interpretation.
-
Oteseconazole: Translating CYP51 Selectivity Into Assays
2026-08-23
Oteseconazole (VT-1161) is more than a potent Candida-active azole: its fungal CYP51 selectivity creates a framework for better assay design and translational interpretation. This article connects mechanism, susceptibility testing, resistance biology, and the latest deuterated CYP51 inhibitor research.
-
PSPro Maps Spatial Proteomes at Cell-Type Resolution
2026-08-22
Mao et al. introduce PSPro, a proximity-labeling workflow that captures cell-type-specific proteomes directly from complex tissue slices while preserving spatial information. By combining optimized antibody-targeted labeling, affinity purification, and optional laser microdissection, the study profiles multiple cell types in pancreatic tumor and spleen tissue and resolves regional proteome heterogeneity.
-
RHO P347L Retinitis Pigmentosa: Endocytosis and Stress
2026-08-22
The 2026 study compares Class 1 RHO P347L and Class 2 RHO L125R mutations in humanized models to explain why P347L disease progresses more severely. Its evidence connects defective outer-segment trafficking, enhanced arrestin-associated endocytosis, lysosomal overload, and mitochondrial dysfunction, while indicating that neuroinflammation is a shared rather than severity-defining feature.
-
Epalrestat: Reframing Polyol Pathway Translation
2026-08-21
A translational framework for using Epalrestat to connect polyol pathway inhibition, oxidative stress research, diabetic neuropathy research, neuroprotection, and emerging questions in fructose-driven cancer metabolism.
-
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
2026-08-20
This DMSO-soluble α2-adrenergic receptor agonist supports mechanistic studies of receptor signaling, immune rejection modulation, and post-surgical osteosarcoma recurrence models. The article translates reference findings into practical cell, hydrogel, and immune-assay workflows with troubleshooting guidance for solvent control, stability, and interpretation.
-
Itraconazole in Candida Biofilm Research
2026-08-20
Itraconazole is a triazole antifungal agent that can connect direct fungal growth assays with Candida biofilm, CYP3A4, and host-signaling studies. This workflow shows how to control solubility, separate antifungal activity from pathway effects, and translate PP2A–autophagy findings into more informative experiments.
-
Antipyrine B1886: CNS Workflow Benchmark
2026-08-19
Antipyrine, also called 1,5-dimethyl-2-phenylpyrazol-3-one, is a research-grade analgesic and antipyretic compound with reported high solubility and 99.98% purity. It can support pharmacokinetic studies and drug metabolism research, but its product specifications do not independently establish blood-brain barrier permeability.
-
Pravastatin Sodium: A Transporter-Aware Assay Strategy
2026-08-19
Pravastatin sodium is a powerful HMG-CoA reductase inhibitor, but its cellular effects depend on uptake, viability, and assay context. This guide combines cholesterol biology with hepatocyte transporter findings to improve experimental design and interpretation.
-
Firefly Luciferase mRNA: LNP Assay Guide
2026-08-18
Use Firefly Luciferase mRNA (ARCA, 5-moUTP) as a sensitive control for transfection, translation, cell viability workflows, and in vivo delivery studies. This guide connects practical reporter assay design with freeze-thaw LNP findings, helping researchers distinguish mRNA integrity problems from nanoparticle delivery failures.
-
Caspofungin: Reading Glucan-Targeting Assays
2026-08-18
Caspofungin is a lipopeptide antifungal drug whose value extends beyond potent glucan synthase inhibition. This article explains how to interpret susceptibility, persistence, resistance, and in vivo endpoints when evaluating Candida therapeutics.